Video Player is loading.
NYU Study finds patients given Hydroxychloroquine + Zinc 44% less likely to die from COVID-19
Buck The System - 417 Ansichten
0
0
Veröffentlicht auf 18 May 2020 / Im Film & Animation
Researchers at NYU's Grossman School of Medicine found patients given the antimalarial drug hydroxychloroquine along with zinc sulphate and the antibiotic azithromycin were 44 percent less likely to die from the coronavirus.
Zeig mehr
0 Bemerkungen
sort Sortiere nach